Paul Hudson joined Sanofi as CEO on September 1, 2019.
Previously CEO of Novartis Pharmaceuticals, where he was a member of the Executive Committee, Hudson has an expansive international career in healthcare that spans the U.S., Japan and Europe.
Prior to Novartis, he worked for AstraZeneca, where he held several increasingly senior positions and most recently carried out the roles of president, AstraZeneca United States and executive vice president, North America.
He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo U.K. Hudson holds a degree in economics from Manchester Metropolitan University in the U.K. and last year his alma mater awarded him an honorary Doctor of Business Administration for his achievements in industry. He also holds a diploma in marketing from the Chartered Institute of Marketing, also in the U.K.